No Data
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer
LivaNova Announces RECOVER Clinical Study Shows Meaningful Benefits Of It's VNS Therapy System In Select Secondary Endpoints For Unipolar Patients With Treatment-Resistant Depression; Results Published In Two Articles In 'Brain Stimulation'
Express News | LivaNova PLC - Active Treatment Arm Showed Significant Improvement Despite Primary Endpoint Not Met
Express News | Recover Clinical Study Shows Meaningful Benefits of Livanova’s Vns Therapy System in Select Secondary Endpoints for Unipolar Patients With Treatment-Resistant Depression
RECOVER Clinical Study Shows Meaningful Benefits of LivaNova's VNS Therapy System in Select Secondary Endpoints for Unipolar Patients With Treatment-Resistant Depression
"Laggard" Stocks With Expanding FCF Margins and Attractive FCF Yields – Goldman
